![](/img/cover-not-exists.png)
Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials
Rustin, Gordon J. S., Nelstrop, Ann E., Bentzen, Søren M., Bond, Simon J., McClean, PatrickVolume:
18
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2000.18.8.1733
Date:
April, 2000
File:
PDF, 61 KB
english, 2000